Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling

Epilepsia

Volumn 51, Issue SUPPL. 3, 2010, Pages 39-42

  Sankar, Raman ^a   Auvin, Stéphane ^b   Kwon, Young Se ^c   Pineda, Eduardo ^a   Shin, Don ^a   Mazarati, Andréy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c Inha University   (South Korea)

Author keywords

Development; Epileptogenesis; Hippocampus; Rapid kindling

Indexed keywords

BUMETANIDE; ETIRACETAM; LAMOTRIGINE; RAPAMYCIN; RETIGABINE; TOPIRAMATE;

CONFERENCE PAPER; EPILEPTIC STATE; EPILEPTOGENESIS; HIPPOCAMPUS; KINDLING; NONHUMAN; PRIORITY JOURNAL;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; BUMETANIDE; CARBAMATES; DISEASE MODELS, ANIMAL; FRUCTOSE; HIPPOCAMPUS; KINDLING, NEUROLOGIC; PHENYLENEDIAMINES; RATS;

EID: 77954484144     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02607.x     Document Type: Conference Paper

References (23)

1. Amano K, Hamada K, Yagi K, Seino M. (1998) Antiepileptic effects of topiramate on amygdaloid kindling in rats. Epilepsy Res 31:123-128. (Pubitemid 28361759)
2. Ben-Ari Y. (2002) Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci 3:728-739.
3. Dzhala VI, Talos DM, Sdrulla DA, Brumback AC, Mathews GC, Benke TA, Delpire E, Jensen FE, Staley KJ. (2005) NKCC1 transporter facilitates seizures in the developing brain. Nat Med 11:1205-1213.
4. Hannaert P, Alvarez-Guerra M, Pirot D, Nazaret C, Garay RP. (2002) Rat NKCC2/NKCC1 cotransporter selectivity for loop diuretic drugs. Naunyn Schmiedebergs Arch Pharmacol 365:193-199. (Pubitemid 34212230)
5. Kokaia M, Holmberg K, Nanobashvili A, Xu ZQ, Kokaia Z, Lendahl U, Hilke S, Theodorsson E, Kahl U, Bartfai T, Lindvall O, Hçkfelt T. (2001) Suppressed kindling epileptogenesis in mice with ectopic over-expression of galanin. Proc Natl Acad Sci U S A 98:14006-14011.
6. Löscher W, Hönack D, Rundfeldt C. (1998) Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 284:474-479. (Pubitemid 28086631)
7. Lothman EW, Hatlelid JM, Zorumski CF, Conry JA, Moon PF, Perlin JB. (1985) Kindling with rapidly recurring hippocampal seizures. Brain Res 360:83-91.
8. Mazarati A, Lundström L, Sollenberg U, Shin D, Langel U, Sankar R. (2006) Regulation of kindling epileptogenesis by hippocampal galanin type 1 and type 2 receptors: the effects of subtype-selective agonists and the role of G-protein-mediated signaling. J Pharmacol Exp Ther 318:700-708.
9. Mazarati A, Shin D, Auvin S, Sankar R. (2007) Age-dependent effects of topiramate on the acquisition and the retention of rapid kindling. Epilepsia 48:765-773.
10. Mazarati A, Wu J, Shin D, Kwon YS, Sankar R. (2008) Antiepileptogenic and antiictogenic effects of retigabine under conditions of rapid kindling: an ontogenic study. Epilepsia 49:1777-1786.
11. Mazarati A, Shin D, Sankar R. (2009) Bumetanide inhibits rapid kindling in neonatal rats. Epilepsia 50:2117-2122.
12. Michelson HB, Lothman EW. (1991) An ontogenetic study of kindling using rapidly recurring hippocampal seizures. Brain Res Dev Brain Res 61:79-85.
13. Morimoto K, Fahnestock M, Racine RJ. (2004) Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73:1-60.
14. Nissinen J, Large CH, Stratton SC, Pitkänen A. (2004) Effect of lamotrigine treatment on epileptogenesis: an experimental study in rat. Epilepsy Res 58:119-132.
15. Postma T, Krupp E, Li XL, Post RM, Weiss SR. (2000) Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy. Epilepsia 41:1514-1521.
16. Stables JP, Bertram E, Dudek FE, Holmes G, Mathern G, Pitkänen A, White HS. (2003) Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/ NINDS/AES models II workshop. Epilepsia 44:1472-1478.
17. Stratton SC, Large CH, Cox B, Davies G, Hagan RM. (2003) Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model. Epilepsy Res 53:95-106.
18. Suchomelova L, Baldwin RA, Kubova H, Thompson KW, Sankar R, Wasterlain CG. (2006) Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects. Pediatr Res 59:237-243.
19. White HS. (2003) Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia 44(suppl 7):2-8.
20. 2007 NINDS Epilepsy Research Benchmarks. http://www.ninds.nih.gov/ research/epilepsyweb/2007-benchmarks.htm#benchmarks
21. Yamada J, Okabe A, Toyoda H, Kilb W, Luhmann HJ, Fukuda A. (2004) Cl- uptake promoting depolarizing GABA actions in immature rat neocortical neurons is mediated by NKCC1. J Physiol 557:829-841.
22. Zeng LH, Xu L, Gutmann DH, Wong M. (2008) Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63:444-453.
23. Zeng LH, Rensing NR, Wong M. (2009) The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci 29:6964-6972.